SynthesisFrontiers in immunology2024

Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis.

Changhui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.